Skip to main content
Journal cover image

The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.

Publication ,  Journal Article
Loizeau, AJ; D'Agata, EMC; Shaffer, ML; Hanson, LC; Anderson, RA; Tsai, T; Habtemariam, DA; Bergman, EH; Carroll, RP; Cohen, SM; Scott, EME ...
Published in: Trials
October 2019

Infections are common in nursing home (NH) residents with advanced dementia but are often managed inappropriately. Antimicrobials are extensively prescribed, but frequently with insufficient evidence to support a bacterial infection, promoting the emergence of multidrug-resistant organisms. Moreover, the benefits of antimicrobials remain unclear in these seriously ill residents for whom comfort is often the goal of care. Prior NH infection management interventions evaluated in randomized clinical trials (RCTs) did not consider patient preferences and lack evidence to support their effectiveness in 'real-world' practice.This report presents the rationale and methodology of TRAIN-AD (Trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias), a parallel group, cluster RCT evaluating a multicomponent intervention to improve infection management for suspected urinary tract infections (UTIs) and lower respiratory tract infections (LRIs) among NH residents with advanced dementia. TRAIN-AD is being conducted in 28 facilities in the Boston, USA, area randomized in waves using minimization to achieve a balance on key characteristics (N = 14 facilities/arm). The involvement of the facilities includes a 3-month start-up period and a 24-month implementation/data collection phase. Residents are enrolled during the first 12 months of the 24-month implementation period and followed for up to 12 months. Individual consent is waived, thus almost all eligible residents are enrolled (target sample size, N = 410). The intervention integrates infectious disease and palliative care principles and includes provider training delivered through multiple modalities (in-person seminar, online course, management algorithms, and prescribing feedback) and an information booklet for families. Control facilities employ usual care. The primary outcome, abstracted from the residents' charts, is the number of antimicrobial courses prescribed for UTIs and LRIs per person-year alive.TRAIN-AD is the first cluster RCT testing a multicomponent intervention to improve infection management in NH residents with advanced dementia. Its findings will provide an evidence base to support the benefit of a program addressing the critical clinical and public health problem of antimicrobial misuse in these seriously ill residents. Moreover, its hybrid efficacy-effectiveness design will inform the future conduct of cluster RCTs evaluating nonpharmacological interventions in the complex NH setting in a way that is both internally valid and adaptable to the 'real-world'.ClinicalTrials.gov, NCT03244917 . Registered on 10 August 2017.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Trials

DOI

EISSN

1745-6215

ISSN

1745-6215

Publication Date

October 2019

Volume

20

Issue

1

Start / End Page

594

Related Subject Headings

  • Urinary Tract Infections
  • Unnecessary Procedures
  • Treatment Outcome
  • Time Factors
  • Respiratory Tract Infections
  • Randomized Controlled Trials as Topic
  • Nursing Homes
  • Multicenter Studies as Topic
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Loizeau, A. J., D’Agata, E. M. C., Shaffer, M. L., Hanson, L. C., Anderson, R. A., Tsai, T., … Mitchell, S. L. (2019). The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial. Trials, 20(1), 594. https://doi.org/10.1186/s13063-019-3675-y
Loizeau, Andrea J., Erika M. C. D’Agata, Michele L. Shaffer, Laura C. Hanson, Ruth A. Anderson, Timothy Tsai, Daniel A. Habtemariam, et al. “The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.Trials 20, no. 1 (October 2019): 594. https://doi.org/10.1186/s13063-019-3675-y.
Loizeau, Andrea J., et al. “The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.Trials, vol. 20, no. 1, Oct. 2019, p. 594. Epmc, doi:10.1186/s13063-019-3675-y.
Loizeau AJ, D’Agata EMC, Shaffer ML, Hanson LC, Anderson RA, Tsai T, Habtemariam DA, Bergman EH, Carroll RP, Cohen SM, Scott EME, Stevens E, Whyman JD, Bennert EH, Mitchell SL. The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial. Trials. 2019 Oct;20(1):594.
Journal cover image

Published In

Trials

DOI

EISSN

1745-6215

ISSN

1745-6215

Publication Date

October 2019

Volume

20

Issue

1

Start / End Page

594

Related Subject Headings

  • Urinary Tract Infections
  • Unnecessary Procedures
  • Treatment Outcome
  • Time Factors
  • Respiratory Tract Infections
  • Randomized Controlled Trials as Topic
  • Nursing Homes
  • Multicenter Studies as Topic
  • Middle Aged
  • Male